Clinical protocol for treatment advance prostate carcinoma with dendritic cells loaded with apoptotic cells
The vaccine is composed by autologous DCs pulsed with apoptotic allogenic prostate carcinoma cell line LNCap.
Vaccination of patients
Patients with advanced prostate carcinoma are vaccinated with the DC vaccine.
Autologous DC are pulsed with the apoptotic allogenic prostate carcinoma cell line LNCap to produce the vaccine for patients with advanced prostate carcinoma..